Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart

被引:11
作者
Luijkx, Tim [1 ]
Cramer, Maarten J. [2 ]
Buckens, Constantinus F. [1 ,3 ]
Zaidi, Abbas [4 ]
Rienks, Rienk [2 ,5 ]
Mosterd, Arend [2 ,3 ,6 ]
Prakken, Niek H. J. [1 ]
Dijkman, Barbara [2 ]
Mali, Willem P. Th M. [1 ]
Velthuis, Birgitta K. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiol, NL-3584 CX Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Cardiol, NL-3584 CX Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands
[4] Univ London, Dept Cardiovasc Sci, London, England
[5] Cent Mil Hosp, Dept Cardiol, Utrecht, Netherlands
[6] Meander Med Ctr, Dept Cardiol, Amersfoort, Netherlands
关键词
LEFT-VENTRICULAR HYPERTROPHY; MAGNETIC-RESONANCE; TASK-FORCE; ETHNIC-DIFFERENCES; SURFACE-AREA; ADAPTATION; PREVALENCE; RELEVANCE; DIAGNOSIS; EXERCISE;
D O I
10.1136/bjsports-2013-092360
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Background Differentiating physiological left ventricular hypertrophy (LVH) in athletes from pathological hypertrophic cardiomyopathy (HCM) can be challenging. This study assesses the ability of cardiac MRI (CMR) to distinguish between physiological LVH (so-called athlete's heart) and HCM. Methods 45 patients with HCM (71% men and 20% athletic) and 734 healthy control participants (60% men and 75% athletic) underwent CMR. Quantitative ventricular parameters were used for multivariate logistic regression with age, gender, sport status and left ventricular (LV) end-diastolic volume (EDV) to ED ventricular wall mass (EDM) ratio as covariates. A second model added the LV EDV : right ventricular (RV) EDV ratio. The performance of the model was subsequently tested. Results LV EDM was greater in patients with HCM (74 g/m(2)) compared with healthy athletes/non-athletes (53/41 g/m(2)), while LV EDV was largest in athletes (114 ml/m(2)) as compared with non-athletes (94 ml/m(2)) and patients with HCM (88 ml/m(2)). The LV EDV : EDM ratio was significantly lower in patients with HCM compared with healthy controls and athletes (1.30/2.39/2.25, p<0.05). The LV EDV : RV EDV ratio was significantly greater in patients with HCM (1.10) than in healthy participants (non-athletes/athletes 0.94/0.93). The regression model resulted in high sensitivity and specificity levels in all and borderline-LVH participants (as defined by septal wall thickness). Corresponding areas under the receiver operator characteristic (ROC) curves were 0.995 (all participants) and 0.992 (borderline-LVH participants only). Adding the LV EDV : RV EDV ratio yielded no additional improvement. Conclusions A model incorporating the LV EDV : EDM ratio can help distinguish HCM from physiological hypertrophy in athletes. This also applies to cases with borderline LVH, which present the greatest diagnostic challenge in clinical practice.
引用
收藏
页码:1404 / 1409
页数:7
相关论文
共 36 条
[1]  
[Anonymous], 2008, Open Magn. Reson. J, DOI [10.2174/1874769800801010104, DOI 10.2174/1874769800801010104]
[2]   Ethnic differences in left ventricular remodeling in highly-trained athletes - Relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy [J].
Basavarajaiah, Sandeep ;
Boraita, Araceli ;
Whyte, Gregory ;
Wilson, Mathew ;
Carby, Lorna ;
Shah, Ajay ;
Sharma, Sanjay .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (23) :2256-2262
[3]   Prevalence of hypertrophic cardiomyopathy in highly trained athletes: Relevance to pre-participation screening [J].
Basavarajaiah, Sandeep ;
Wilson, Matthew ;
Whyte, Gregory ;
Shah, Ajay ;
McKenna, William ;
Sharma, Sanjay .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) :1033-1039
[4]   Three-Dimensional Echocardiographic Characterization of Left Ventricular Remodeling in Olympic Athletes [J].
Caselli, Stefano ;
Di Paolo, Fernando M. ;
Pisicchio, Cataldo ;
Di Pietro, Riccardo ;
Quattrini, Filippo M. ;
Di Giacinto, Barbara ;
Culasso, Franco ;
Pelliccia, Antonio .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (01) :141-147
[5]   Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy [J].
Choudhury, L ;
Mahrholdt, H ;
Wagner, A ;
Choi, KM ;
Elliott, MD ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM ;
Kim, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (12) :2156-2164
[6]   Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study [J].
De Castro, Stefano ;
Caselli, Stefano ;
Maron, Martin ;
Pelliccia, Antonio ;
Cavarretta, Elena ;
Maddukuri, Prasad ;
Cartoni, Domenico ;
Di Angelantonio, Emanuele ;
Kuvin, Jeffrey T. ;
Patel, Ayan R. ;
Pandian, Natesa G. .
HEART, 2007, 93 (02) :205-209
[7]  
Du Bois D, 1989, Nutrition, V5, P303
[8]   2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].
Gersh, Bernard J. ;
Maron, Barry J. ;
Bonow, Robert O. ;
Dearani, Joseph A. ;
Fifer, Michael A. ;
Link, Mark S. ;
Naidu, Srihari S. ;
Nishimura, Rick A. ;
Ommen, Steve R. ;
Rakowski, Harry ;
Seidman, Christine E. ;
Towbin, Jeffrey A. ;
Udelson, James E. ;
Yancy, Clyde W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) :E212-E260
[9]  
Harrell FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1
[10]   Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy - In vivo imaging of the pathologic substrate for premature cardiac death? [J].
Kim, RJ ;
Judd, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) :1568-1572